Sirnaomics

In News

Sirnaomics: Loss narrowed, R&D focus sharpened, and cash reserves declined amid ongoing partnership efforts - TradingView

TradingView - Aug 28, 2026

Sirnaomics Commence Treatment of Facial Squamous Cell Skin Cancer In Situ - BioPharma APAC

BioPharma APAC - Jul 06, 2026

Sirnaomics Announces RMB30 Million Capital Injection For Deemed Disposal - TradingView

TradingView - Aug 26, 2026

Sirnaomics Sues Founder Lu Yang to Recover Responsibility for $20 Million Investment Loss - finance.biggo.com

finance.biggo.com - Aug 14, 2026

Sirnaomics Sues Former Executives Over US$20M Investment - marketscreener.com

marketscreener.com - Aug 17, 2026

Cash-strapped Sirnaomics seeks lifeline in cosmetic treatments - thebambooworks.com

thebambooworks.com - Aug 20, 2026

Sirnaomics: a unique, clinical-phase RNA therapeutic innovator on the global stage - Nature

Nature - May 16, 2022

Sirnaomics concludes second cohort of Phase I RNAi therapeutic trial - Clinical Trials Arena

Clinical Trials Arena - Jul 08, 2024

MoCo biopharma Sirnaomics raises another nine-figure round - The Business Journals

The Business Journals - Jul 06, 2021

Coronavirus: China tests AbbVie’s HIV drugs; Sirnaomics to develop drugs - Pharmaceutical Technology

Pharmaceutical Technology - Jan 27, 2020

Sirnaomics Secures HKD 138 Million Strategic Investment from Bloomage Biotech - BioPharma APAC

BioPharma APAC - Sep 09, 2025

Clifford Chance advises Sirnaomics on its Chapter 18A Hong Kong IPO and listing - Clifford Chance

Clifford Chance - Dec 30, 2021

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment